{"id":1628,"date":"2020-07-21T11:34:58","date_gmt":"2020-07-21T11:34:58","guid":{"rendered":"https:\/\/bxta-staging.website\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\/"},"modified":"2021-09-14T21:33:48","modified_gmt":"2021-09-14T21:33:48","slug":"patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control","status":"publish","type":"post","link":"https:\/\/bxta.com\/es\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\/","title":{"rendered":"Los pacientes tratados con Braquiterapia de Baja Dosis para potenciar el tratamiento en combinaci\u00f3n con la Radioterapia de Haz Externo consiguen un control del PSA m\u00e1s efectivo."},"content":{"rendered":"<div>\n<div>Las nuevas investigaciones llevadas a cabo originariamente en hospitales de formaci\u00f3n del NHS, seg\u00fan las publicaciones de Elsevier en Journal of Clinical and Translational Radiation Oncology, revelaron que los hombres con c\u00e1ncer de pr\u00f3stata de riesgo intermedio o elevado que han sido tratados con braquiterapia de dosis baja reforzada con radioterapia de Haz Externo (LDR-EBRT) consiguen un mayor control efectivo del PSA en un periodo de post-tratamiento de cinco a\u00f1os que los hombres que han sido tratados con un tratamiento de braquiterapia de alta dosis (HDR-EBRT).<\/div>\n<div>El escalado de dosis ha resultado ser eficaz para mejorar la supervivencia libre de progresi\u00f3n bioqu\u00edmica (bPFS), o mejora del control de PSA, en c\u00e1ncer localizado de pr\u00f3stata. El escalado de dosis se puede realizar de varias maneras: mediante la Radioterapia de Haz Externo (EBRT) por separado, mediante braquiterapia, o mediante una combinaci\u00f3n de ambas. Varios estudios de pacientes con riesgo moderado y elevado de c\u00e1ncer de pr\u00f3stata han demostrado una mejor\u00eda de la bPFS tanto para la dosis alta de braquiterapia en combinaci\u00f3n con el EBRT (HDR-EBRT) como con la braquiterapia con semillas permanentes a dosis bajas en combinaci\u00f3n con el EBRT (LDR-EBRT) en comparaci\u00f3n con el EBRT por separado. Sin embargo, faltaban resultados de la comparaci\u00f3n de la LDR-EBRT con la HDR-EBRT.<\/div>\n<div>El estudio realizado en Leeds compar\u00f3 los resultados de 116 hombres tratados con LDR-EBRT y 171 tratados con HDR-EBRT entre 1996 y 2007, y 2007-2012 respectivamente. Se vio que los pacientes tratados con HDR-EBRT ten\u00edan dos veces m\u00e1s probabilidades de experimentar una mejora bioqu\u00edmica (PSA elevado) frente a los de LDR-EBRT, lo cual significa que los pacientes tratados con LDR-EBRT ten\u00edan m\u00e1s probabilidades de controlar la enfermedad.<\/div>\n<div>El PSA es un indicador importante a largo plazo del bPFS en hombres tratados de c\u00e1ncer de pr\u00f3stata y se asocia un nivel de PSA menor a un mejor resultado.<\/div>\n<div>Con los diagn\u00f3sticos de c\u00e1ncer de pr\u00f3stata en aumento y una mayor inversi\u00f3n en su diagn\u00f3stico y tratamiento, es m\u00e1s importante que nunca que los hombres diagnosticados est\u00e9n seguros de su investigaci\u00f3n y que busquen consejo sobre las diferentes opciones de tratamiento que disponen, as\u00ed como de las tasas de supervivencia libre de c\u00e1ncer de pr\u00f3stata.<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>New original research from Leeds Teaching Hospitals NHS Trust, as published in Elsevier\u2019s Journal of Clinical and Translational Radiation Oncology, has revealed that men with intermediate- and high-risk prostate cancer treated with a low dose rate brachytherapy boost in combination with external beam radiotherapy (LDR-EBRT) achieve more effective PSA control over a five year post-treatment period than men treated with a high dose rate brachytherapy boost (HDR-EBRT).Dose escalation has been shown<\/p>","protected":false},"author":10,"featured_media":1045,"comment_status":"open","ping_status":"open","sticky":false,"template":"template-old-blog.php","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[7],"tags":[],"class_list":["post-1628","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-resources"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Patients treated with Low Dose Rate Brachytherapy boost therapy in combination with External Beam Radiotherapy achieve more effective PSA control - BXTA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bxta.com\/es\/fr\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Patients treated with Low Dose Rate Brachytherapy boost therapy in combination with External Beam Radiotherapy achieve more effective PSA control - BXTA\" \/>\n<meta property=\"og:description\" content=\"New original research from Leeds Teaching Hospitals NHS Trust, as published in Elsevier\u2019s Journal of Clinical and Translational Radiation Oncology, has revealed that men with intermediate- and high-risk prostate cancer treated with a low dose rate brachytherapy boost in combination with external beam radiotherapy (LDR-EBRT) achieve more effective PSA control over a five year post-treatment period than men treated with a high dose rate brachytherapy boost (HDR-EBRT).Dose escalation has been shown\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bxta.com\/es\/fr\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\/\" \/>\n<meta property=\"og:site_name\" content=\"BXTA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/bxtainternational\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-21T11:34:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-09-14T21:33:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bxta.com\/wp-content\/uploads\/2020\/08\/J1mxDC_g-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1480\" \/>\n\t<meta property=\"og:image:height\" content=\"1015\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marketing BXTA\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BXTA_\" \/>\n<meta name=\"twitter:site\" content=\"@BXTA_\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marketing BXTA\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/bxta.com\\\/fr\\\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/fr\\\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\\\/\"},\"author\":{\"name\":\"Marketing BXTA\",\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#\\\/schema\\\/person\\\/be7f4368cd4f7e11918870d00223473a\"},\"headline\":\"Patients treated with Low Dose Rate Brachytherapy boost therapy in combination with External Beam Radiotherapy achieve more effective PSA control\",\"datePublished\":\"2020-07-21T11:34:58+00:00\",\"dateModified\":\"2021-09-14T21:33:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/fr\\\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\\\/\"},\"wordCount\":327,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/fr\\\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bxta.com\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/J1mxDC_g-scaled.jpeg\",\"articleSection\":[\"Resources\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bxta.com\\\/fr\\\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\\\/\",\"url\":\"https:\\\/\\\/bxta.com\\\/fr\\\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\\\/\",\"name\":\"Patients treated with Low Dose Rate Brachytherapy boost therapy in combination with External Beam Radiotherapy achieve more effective PSA control - BXTA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/fr\\\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/fr\\\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bxta.com\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/J1mxDC_g-scaled.jpeg\",\"datePublished\":\"2020-07-21T11:34:58+00:00\",\"dateModified\":\"2021-09-14T21:33:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/fr\\\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/bxta.com\\\/fr\\\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/bxta.com\\\/fr\\\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\\\/#primaryimage\",\"url\":\"https:\\\/\\\/bxta.com\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/J1mxDC_g-scaled.jpeg\",\"contentUrl\":\"https:\\\/\\\/bxta.com\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/J1mxDC_g-scaled.jpeg\",\"width\":1480,\"height\":1015},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bxta.com\\\/fr\\\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/bxta.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Patients treated with Low Dose Rate Brachytherapy boost therapy in combination with External Beam Radiotherapy achieve more effective PSA control\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#website\",\"url\":\"https:\\\/\\\/bxta.com\\\/uk\\\/\",\"name\":\"BXTA\",\"description\":\"Let\u2019s tackle Prostate Cancer together | BXTA\",\"publisher\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/bxta.com\\\/uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#organization\",\"name\":\"BXTA\",\"url\":\"https:\\\/\\\/bxta.com\\\/uk\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/bxta-staging.s3.eu-west-2.amazonaws.com\\\/app\\\/uploads\\\/2021\\\/09\\\/07212056\\\/BXTA-Logo.png\",\"contentUrl\":\"https:\\\/\\\/bxta-staging.s3.eu-west-2.amazonaws.com\\\/app\\\/uploads\\\/2021\\\/09\\\/07212056\\\/BXTA-Logo.png\",\"width\":600,\"height\":373,\"caption\":\"BXTA\"},\"image\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/bxtainternational\\\/\",\"https:\\\/\\\/x.com\\\/BXTA_\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/bxtaccelyon\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCkTU9L10CS5c1eWtGiMZ7gw\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#\\\/schema\\\/person\\\/be7f4368cd4f7e11918870d00223473a\",\"name\":\"Marketing BXTA\",\"url\":\"https:\\\/\\\/bxta.com\\\/es\\\/author\\\/marketingbxta\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Patients treated with Low Dose Rate Brachytherapy boost therapy in combination with External Beam Radiotherapy achieve more effective PSA control - BXTA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bxta.com\/es\/fr\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\/","og_locale":"es_ES","og_type":"article","og_title":"Patients treated with Low Dose Rate Brachytherapy boost therapy in combination with External Beam Radiotherapy achieve more effective PSA control - BXTA","og_description":"New original research from Leeds Teaching Hospitals NHS Trust, as published in Elsevier\u2019s Journal of Clinical and Translational Radiation Oncology, has revealed that men with intermediate- and high-risk prostate cancer treated with a low dose rate brachytherapy boost in combination with external beam radiotherapy (LDR-EBRT) achieve more effective PSA control over a five year post-treatment period than men treated with a high dose rate brachytherapy boost (HDR-EBRT).Dose escalation has been shown","og_url":"https:\/\/bxta.com\/es\/fr\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\/","og_site_name":"BXTA","article_publisher":"https:\/\/www.facebook.com\/bxtainternational\/","article_published_time":"2020-07-21T11:34:58+00:00","article_modified_time":"2021-09-14T21:33:48+00:00","og_image":[{"width":1480,"height":1015,"url":"https:\/\/bxta.com\/wp-content\/uploads\/2020\/08\/J1mxDC_g-scaled.jpeg","type":"image\/jpeg"}],"author":"Marketing BXTA","twitter_card":"summary_large_image","twitter_creator":"@BXTA_","twitter_site":"@BXTA_","twitter_misc":{"Escrito por":"Marketing BXTA","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bxta.com\/fr\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\/#article","isPartOf":{"@id":"https:\/\/bxta.com\/fr\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\/"},"author":{"name":"Marketing BXTA","@id":"https:\/\/bxta.com\/uk\/#\/schema\/person\/be7f4368cd4f7e11918870d00223473a"},"headline":"Patients treated with Low Dose Rate Brachytherapy boost therapy in combination with External Beam Radiotherapy achieve more effective PSA control","datePublished":"2020-07-21T11:34:58+00:00","dateModified":"2021-09-14T21:33:48+00:00","mainEntityOfPage":{"@id":"https:\/\/bxta.com\/fr\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\/"},"wordCount":327,"commentCount":0,"publisher":{"@id":"https:\/\/bxta.com\/uk\/#organization"},"image":{"@id":"https:\/\/bxta.com\/fr\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\/#primaryimage"},"thumbnailUrl":"https:\/\/bxta.com\/wp-content\/uploads\/2020\/08\/J1mxDC_g-scaled.jpeg","articleSection":["Resources"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/bxta.com\/fr\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\/","url":"https:\/\/bxta.com\/fr\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\/","name":"Patients treated with Low Dose Rate Brachytherapy boost therapy in combination with External Beam Radiotherapy achieve more effective PSA control - BXTA","isPartOf":{"@id":"https:\/\/bxta.com\/uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/bxta.com\/fr\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\/#primaryimage"},"image":{"@id":"https:\/\/bxta.com\/fr\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\/#primaryimage"},"thumbnailUrl":"https:\/\/bxta.com\/wp-content\/uploads\/2020\/08\/J1mxDC_g-scaled.jpeg","datePublished":"2020-07-21T11:34:58+00:00","dateModified":"2021-09-14T21:33:48+00:00","breadcrumb":{"@id":"https:\/\/bxta.com\/fr\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bxta.com\/fr\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/bxta.com\/fr\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\/#primaryimage","url":"https:\/\/bxta.com\/wp-content\/uploads\/2020\/08\/J1mxDC_g-scaled.jpeg","contentUrl":"https:\/\/bxta.com\/wp-content\/uploads\/2020\/08\/J1mxDC_g-scaled.jpeg","width":1480,"height":1015},{"@type":"BreadcrumbList","@id":"https:\/\/bxta.com\/fr\/patients-treated-with-low-dose-rate-brachytherapy-boost-therapy-in-combination-with-external-beam-radiotherapy-achieve-more-effective-psa-control\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bxta.com\/"},{"@type":"ListItem","position":2,"name":"Patients treated with Low Dose Rate Brachytherapy boost therapy in combination with External Beam Radiotherapy achieve more effective PSA control"}]},{"@type":"WebSite","@id":"https:\/\/bxta.com\/uk\/#website","url":"https:\/\/bxta.com\/uk\/","name":"BXTA","description":"Hagamos frente juntos al c\u00e1ncer de pr\u00f3stata | BXTA","publisher":{"@id":"https:\/\/bxta.com\/uk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bxta.com\/uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/bxta.com\/uk\/#organization","name":"BXTA","url":"https:\/\/bxta.com\/uk\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/bxta.com\/uk\/#\/schema\/logo\/image\/","url":"https:\/\/bxta-staging.s3.eu-west-2.amazonaws.com\/app\/uploads\/2021\/09\/07212056\/BXTA-Logo.png","contentUrl":"https:\/\/bxta-staging.s3.eu-west-2.amazonaws.com\/app\/uploads\/2021\/09\/07212056\/BXTA-Logo.png","width":600,"height":373,"caption":"BXTA"},"image":{"@id":"https:\/\/bxta.com\/uk\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/bxtainternational\/","https:\/\/x.com\/BXTA_","https:\/\/www.linkedin.com\/company\/bxtaccelyon","https:\/\/www.youtube.com\/channel\/UCkTU9L10CS5c1eWtGiMZ7gw"]},{"@type":"Person","@id":"https:\/\/bxta.com\/uk\/#\/schema\/person\/be7f4368cd4f7e11918870d00223473a","name":"Marketing BXTA","url":"https:\/\/bxta.com\/es\/author\/marketingbxta\/"}]}},"_links":{"self":[{"href":"https:\/\/bxta.com\/es\/wp-json\/wp\/v2\/posts\/1628","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bxta.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bxta.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bxta.com\/es\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/bxta.com\/es\/wp-json\/wp\/v2\/comments?post=1628"}],"version-history":[{"count":2,"href":"https:\/\/bxta.com\/es\/wp-json\/wp\/v2\/posts\/1628\/revisions"}],"predecessor-version":[{"id":1778,"href":"https:\/\/bxta.com\/es\/wp-json\/wp\/v2\/posts\/1628\/revisions\/1778"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bxta.com\/es\/wp-json\/wp\/v2\/media\/1045"}],"wp:attachment":[{"href":"https:\/\/bxta.com\/es\/wp-json\/wp\/v2\/media?parent=1628"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bxta.com\/es\/wp-json\/wp\/v2\/categories?post=1628"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bxta.com\/es\/wp-json\/wp\/v2\/tags?post=1628"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}